Literature DB >> 10860775

Functional evidence for a cyclic-AMP related mechanism of action of the beta(2)-adrenoceptor in human ventricular myocytes.

D L Adamson1, A R Money-Kyrle, S E Harding.   

Abstract

The human ventricle contains both beta(1)- and beta(1)-adrenoceptors (AR) and both have been shown to be present on a single myocyte. In animal ventricular myocardium there is evidence that beta(1)ARs increase cardiac contraction by non-cAMP-dependent mechanisms. We have used the anti-adrenergic effects of carbachol and the cAMP antagonist Rp -cAMPS to investigate the functional contribution of cAMP to beta(2)AR responses in human ventricular myocytes isolated from cardiac biopsies or explants. Concentration-response curves to isoproterenol (Iso) were constructed in the absence and presence of a beta(1)AR antagonist, CGP 207 12A (300 nmol/l) to determine the contribution of the beta(2)AR to contraction. The cells were rechallenged with sub-maximal dose of Iso under beta(2)AR-specific conditions and Rp -cAMPS (100-200 micromol/l) or carbachol (1-3 microm/l) added. Rp -cAMPS significantly decreased contraction amplitude (% shortening; Iso 7.1+/-0.7, Iso+Rp -cAMPS 3.5+/-0.5, n=7, P<0.001) though not completely to the baseline (2.2+/-0.6, n=7). Rechallenge with Iso alone reversed the effects of Rp -cAMPS, and subsequent addition of the beta(1)AR antagonist ICI 118,551 reduced the response to baseline (1.6+/-0.3, n=4) confirming beta(2)AR involvement. Similarly, carbachol decreased Iso-stimulated contraction from 7.5+/-1.2% to 3.2+/-0.9% (P<0.05, n=4), but not completely to basal levels (1.6+/-0.3%). These results provide functional evidence for a predominantly cAMP-mediated mechanism of contractile stimulation by beta(1)ARs in human ventricular myocardium, although a small contribution from a non-cAMP dependent pathway may occur. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860775     DOI: 10.1006/jmcc.2000.1171

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

1.  Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated.

Authors:  Mun-Kit Choy; Mehregan Movassagh; Hock-Guan Goh; Martin R Bennett; Thomas A Down; Roger S Y Foo
Journal:  BMC Genomics       Date:  2010-09-27       Impact factor: 3.969

2.  High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failure.

Authors:  Mun-Kit Choy; Mehregan Movassagh; Lee Siggens; Ana Vujic; Martin Goddard; Ana Sánchez; Neil Perkins; Nichola Figg; Martin Bennett; Jason Carroll; Roger Foo
Journal:  Genome Med       Date:  2010-06-14       Impact factor: 11.117

3.  DNA methylation dysregulations in rheumatic heart valve disease.

Authors:  Kangjun Shen; Hui Liu; Ran Jing; Jiangfeng Yi; Xinmin Zhou
Journal:  BMC Cardiovasc Disord       Date:  2017-06-17       Impact factor: 2.298

4.  Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure.

Authors:  Mehregan Movassagh; Mun-Kit Choy; Martin Goddard; Martin R Bennett; Thomas A Down; Roger S-Y Foo
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

5.  Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human Primary Cardiomyocytes.

Authors:  Najah Abi-Gerges; Tim Indersmitten; Ky Truong; William Nguyen; Phachareeya Ratchada; Nathalie Nguyen; Guy Page; Paul E Miller; Andre Ghetti
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.